Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

(2012) George K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort

(2012) Louise Watson et al.   ARTHRITIS AND RHEUMATISM

Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil

(2012) GMN Daleboudt et al.   LUPUS

Chapter 12: Lupus nephritis

(2012)   Kidney International Supplements

Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus

(2011) Rina Mina et al.   ARTHRITIS CARE & RESEARCH

Pediatric Lupus—Are There Differences in Presentation, Genetics, Response to Therapy, and Damage Accrual Compared with Adult Lupus?

(2010) Rina Mina et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus

(2008) Hermine I. Brunner et al.   ARTHRITIS AND RHEUMATISM

Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil

(2008) Keith K. Lau et al.   Journal of Pediatric Health Care

Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)

(2008) LB Tucker et al.   LUPUS